|
|
|
Volumn 56, Issue 7, 2002, Pages 494-499
|
|
Randomised trial of the effect of orlistat on body weight and cardiovascular disease risk profile in obese patiensts: UK multimorbidity study
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHOLESTEROL;
GLUCOSE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PLACEBO;
TETRAHYDROLIPSTATIN;
TRIACYLGLYCEROL;
ADULT;
AGED;
ARTICLE;
BODY WEIGHT;
CARDIOVASCULAR RISK;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
COMORBIDITY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIASTOLIC BLOOD PRESSURE;
DIET RESTRICTION;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG TOLERABILITY;
FEMALE;
GASTROINTESTINAL TOXICITY;
GLUCOSE BLOOD LEVEL;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
OBESITY;
ORAL GLUCOSE TOLERANCE TEST;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SYSTOLIC BLOOD PRESSURE;
UNITED KINGDOM;
WEIGHT REDUCTION;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTI-OBESITY AGENTS;
BODY MASS INDEX;
CARDIOVASCULAR DISEASES;
CHOLESTEROL;
DOUBLE-BLIND METHOD;
FEMALE;
GREAT BRITAIN;
HUMANS;
LACTONES;
MALE;
MIDDLE AGED;
OBESITY;
RISK FACTORS;
WEIGHT LOSS;
|
|
EID: 0036735197
PISSN: 13685031
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (91)
|
|
References (25)
|
